Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1

Neurobiology of Aging

Volumn 34, Issue 1, 2013, Pages 357.e7-357.e19

  Langefeld, C D ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Age at onset; Amyotrophic lateral sclerosis; Genome wide association study

Indexed keywords

EID: 84868133881     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2012.07.017     Document Type: Article

References (49)

1. Al-Chalabi A., Fang F., Hanby M.F., Leigh P.N., Shaw C.E., Ye W., Rijsdijk F. An estimate of amyotrophic lateral sclerosis heritability using twin data. J. Neurol. Neurosurg. Psychiatry 2010, 81:1324-1326.
2. Al-Chalabi A., Lewis C.M. Modelling the effects of penetrance and family size on rates of sporadic and familial disease. Hum. Hered 2011, 71:281-288.
3. Armon C. Smoking may be considered an established risk factor for sporadic ALS. Neurology 2009, 73:1693-1698.
4. Chiò A., Schymick J.C., Restagno G., Scholz S.W., Lombardo F., Lai S.L., Mora G., Fung H.C., Britton A., Arepalli S., Gibbs J.R., Nalls M., Berger S., Kwee L.C., Oddone E.Z., Ding J., Crews C., Rafferty I., Washecka N., Hernandez D., Ferrucci L., Bandinelli S., Guralnik J., Macciardi F., Torri F., Lupoli S., Chanock S.J., Thomas G., Hunter D.J., Gieger C., Wichmann H.E., Calvo A., Mutani R., Battistini S., Giannini F., Caponnetto C., Mancardi G.L., La Bella V., Valentino F., Monsurrò M.R., Tedeschi G., Marinou K., Sabatelli M., Conte A., Mandrioli J., Sola P., Salvi F., Bartolomei I., Siciliano G., Carlesi C., Orrell R.W., Talbot K., Simmons Z., Connor J., Pioro E.P., Dunkley T., Stephan D.A., Kasperaviciute D., Fisher E.M., Jabonka S., Sendtner M., Beck M., Bruijn L., Rothstein J., Schmidt S., Singleton A., Hardy J., Traynor B.J. A two-stage genome-wide association study of sporadic amyotrophic lateral sclerosis. Hum. Mol. Genet 2009, 18:1524-1532.
5. Chiò A., Traynor B.J., Lombardo F., Fimognari M., Calvo A., Ghiglione P., Mutani R., Restagno G. Prevalence of SOD1 mutations in the Italian ALS population. Neurology 2008, 70:533-537.
6. Cronin S., Berger S., Ding J., Schymick J.C., Washecka N., Hernandez D.G., Greenway M.J., Bradley D.G., Traynor B.J., Hardiman O. A genome-wide association study of sporadic ALS in a homogenous Irish population. Hum. Mol. Genet 2008, 1:768-774.
7. DeJesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.M., Finch N.A., Flynn H., Adamson J., Kouri N., Wojtas A., Sengdy P., Hsiung G.Y., Karydas A., Seeley W.W., Josephs K.A., Coppola G., Geschwind D.H., Wszolek Z.K., Feldman H., Knopman D.S., Petersen R.C., Miller B.L., Dickson D.W., Boylan K.B., Graff-Radford N.R., Rademakers R. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011, 72:245-256.
8. Deng H.X., Chen W., Hong S.T., Boycott K.M., Gorrie G.H., Siddique N., Yang Y., Fecto F., Shi Y., Zhai H., Jiang H., Hirano M., Rampersaud E., Jansen G.H., Donkervoort S., Bigio E.H., Brooks B.R., Ajroud K., Sufit R.L., Haines J.L., Mugnaini E., Pericak-Vance M.A., Siddique T. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature 2011, 477:211-215.
9. Dunckley T., Huentelman M.J., Craig D.W., Pearson J.V., Szelinger S., Joshipura K., Halperin R.F., Stamper C., Jensen K.R., Letizia D., Hesterlee S.E., Pestronk A., Levine T., Bertorini T., Graves M.C., Mozaffar T., Jackson C.E., Bosch P., McVey A., Dick A., Barohn R., Lomen-Hoerth C., Rosenfeld J., O'Connor D.T., Zhang K., Crook R., Ryberg H., Hutton M., Katz J., Simpson E.P., Mitsumoto H., Bowser R., Miller R.G., Appel S.H., Stephan D.A. Whole-genome analysis of sporadic amyotrophic lateral sclerosis. N Engl J. Med 2007, 23:822-823.
10. Fallis B.A., Hardiman O. Aggregation of neurodegenerative disease in ALS kindreds. Amyotroph. Lateral Scler 2009, 10:95-98.
11. Fang F., Kamel F., Lichtenstein P., Bellocco R., Sparén P., Sandler D.P., Ye W. Familial aggregation of amyotrophic lateral sclerosis. Ann. Neurol 2009, 66:94-99.
12. Fogh I., Rijsdijk F., Andersen P.M., Sham P.C., Knight J., Neale B., McKenna-Yasek D., Silani V., Brown R.H., Powell J.F., Al-Chalabi A. Age at onset in sod1-mediated amyotrophic lateral sclerosis shows familiality. Neurogenetics 2007, 8:235-236.
13. Gibbs J.R., van der Brug M.P., Hernandez D.G., Traynor B.J., Nalls M.A., Lai S.L., Arepalli S., Dillman A., Rafferty I.P., Troncoso J., Johnson R., Zielke H.R., Ferrucci L., Longo D.L., Cookson M.R., Singleton A.B. Abundant quantitative trait loci exist for DNA methylation and gene expression in human brain. PLoS Genet 2010, 6:e1000952.
14. Gros-Louis F., Andersen P.M., Dupre N., Urushitani M., Dion P., Souchon F., D'Amour M., Camu W., Meininger V., Bouchard J.P., Rouleau G.A., Julien J.P. Chromogranin B P413L variant as risk factor and modifier of disease onset for amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:21777-21782.
15. Hanby M.F., Scott K.M., Scotton W., Wijesekera L., Mole T., Ellis C.E., Leigh P.N., Shaw C.E., Al-Chalabi A. The risk to relatives of patients with sporadic amyotrophic lateral sclerosis. Brain 2011, 134:3454-3457.
16. Hirtz D., Thurman D.J., Gwinn-Hardy K., Mohamed M., Chaudhuri A.R., Zalutsky R. How common are the "common" neurologic disorders?. Neurology 2007, 68:326-337.
17. Johnson J.O., Mandrioli J., Benatar M., Abramzon Y., Van Deerlin V.M., Trojanowski J.Q., Gibbs J.R., Brunetti M., Gronka S., Wuu J., Ding J., McCluskey L., Martinez-Lage M., Falcone D., Hernandez D.G., Arepalli S., Chong S., Schymick J.C., Rothstein J., Landi F., Wang Y.D., Calvo A., Mora G., Sabatelli M., Monsurrò M.R., Battistini S., Salvi F., Spataro R., Sola P., Borghero G., Galassi G., Scholz S.W., Taylor J.P., Restagno G., Chiò A., Traynor B.J. Exome sequencing reveals VCP mutations as a cause of familial ALS [erratum in: 2011;69:397.]. Neuron 2010, 68:857-864. ITALSGEN Consortium.
18. Johnston C.A., Stanton B.R., Turner M.R., Gray R., Blunt A.H., Butt D., Ampong M.A., Shaw C.E., Leigh P.N., Al-Chalabi A. Amyotrophic lateral sclerosis in an urban setting: a population based study of inner city London. J. Neurol 2006, 253:1642-1643.
19. Kwiatkowski T.J., Bosco D.A., Leclerc A.L., Tamrazian E., Vanderburg C.R., Russ C., Davis A., Gilchrist J., Kasarskis E.J., Munsat T., Valdmanis P., Rouleau G.A., Hosler B.A., Cortelli P., de Jong P.J., Yoshinaga Y., Haines J.L., Pericak-Vance M.A., Yan J., Ticozzi N., Siddique T., McKenna-Yasek D., Sapp P.C., Horvitz H.R., Landers J.E., Brown R.H. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 2009, 323:1205-1208.
20. Laaksovirta H., Peuralinna T., Schymick J.C., Scholz S.W., Lai S.L., Myllykangas L., Sulkava R., Jansson L., Hernandez D.G., Gibbs J.R., Nalls M.A., Heckerman D., Tienari P.J., Traynor B.J. Chromosome 9p21 in amyotrophic lateral sclerosis in Finland: a genome-wide association study. Lancet Neurol 2010, 9:978-985.
21. Landers J.E., Melki J., Meininger V., Glass J.D., van den Berg L.H., van Es M.A., Sapp P.C., van Vught P.W., McKenna-Yasek D.M., Blauw H.M., Cho T.J., Polak M., Shi L., Wills A.M., Broom W.J., Ticozzi N., Silani V., Ozoguz A., Rodriguez-Leyva I., Veldink J.H., Ivinson A.J., Saris C.G., Hosler B.A., Barnes-Nessa A., Couture N., Wokke J.H., Kwiatkowski T.J., Ophoff R.A., Cronin S., Hardiman O., Diekstra F.P., Leigh P.N., Shaw C.E., Simpson C.L., Hansen V.K., Powell J.F., Corcia P., Salachas F., Heath S., Galan P., Georges F., Horvitz H.R., Lathrop M., Purcell S., Al-Chalabi A., Brown R.H. Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:9004-9009.
22. Li Y.J., Pericak-Vance M.A., Haines J.L., Siddique N., McKenna-Yasek D., Hung W.Y., Sapp P., Allen C.I., Chen W., Hosler B., Saunders A.M., Dellefave L.M., Brown R.H., Siddique T. Apolipoprotein E is associated with age at onset of amyotrophic lateral sclerosis. Neurogenetics 2004, 5:209-213.
23. Lill C.M., Abel O., Bertram L., Al-Chalabi A. Keeping up with genetic discoveries in amyotrophic lateral sclerosis: the ALSoD and ALSGene databases. Amyotroph. Lateral Scler 2011, 12:238-249.
24. Logroscino G., Beghi E., Zoccolella S., Palagano R., Fraddosio A., Simone I.L., Lamberti P., Lepore V., Serlenga L. Incidence of amyotrophic lateral sclerosis in southern Italy: a population based study. J. Neurol. Neurosurg. Psychiatry 2005, 76:1094-1098. SLAP Registry.
25. Logroscino G., Traynor B.J., Hardiman O., Chio A., Couratier P., Mitchell J.D., Swingler R.J., Beghi E. Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J. Neurol. Neurosurg. Psychiatry 2008, 79:6-11. EURALS.
26. Manjaly Z.R., Scott K.M., Abhinav K., Wijesekera L., Ganesalingam J., Goldstein L.H., Janssen A., Dougherty A., Willey E., Stanton B.R., Turner M.R., Ampong M.A., Sakel M., Orrell R.W., Howard R., Shaw C.E., Leigh P.N., Al-Chalabi A. The sex ratio in amyotrophic lateral sclerosis: A population based study. Amyotroph. Lateral Scler 2010, 11:439-442.
27. Maruyama H., Morino H., Ito H., Izumi Y., Kato H., Watanabe Y., Kinoshita Y., Kamada M., Nodera H., Suzuki H., Komure O., Matsuura S., Kobatake K., Morimoto N., Abe K., Suzuki N., Aoki M., Kawata A., Hirai T., Kato T., Ogasawara K., Hirano A., Takumi T., Kusaka H., Hagiwara K., Kaji R., Kawakami H. Mutations of optineurin in amyotrophic lateral sclerosis. Nature 2010, 465:223-226.
28. Mitchell J., Morris A., de Belleroche J. Thioredoxin reductase 1 haplotypes modify familial amyotrophic lateral sclerosis onset. Free Radic. Biol. Med 2009, 46:202-211.
29. Nishimura A.L., Mitne-Neto M., Silva H.C., Richieri-Costa A., Middleton S., Cascio D., Kok F., Oliveira J.R., Gillingwater T., Webb J., Skehel P., Zatz M. A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am. J. Hum. Genet 2004, 75:822-831.
30. Oosthuyse B., Moons L., Storkebaum E., Beck H., Nuyens D., Brusselmans K., Van Dorpe J., Hellings P., Gorselink M., Heymans S., Theilmeier G., Dewerchin M., Laudenbach V., Vermylen P., Raat H., Acker T., Vleminckx V., Van Den Bosch L., Cashman N., Fujisawa H., Drost M.R., Sciot R., Bruyninckx F., Hicklin D.J., Ince C., Gressens P., Lupu F., Plate K.H., Robberecht W., Herbert J.M., Collen D., Carmeliet P. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat. Genet 2001, 28:131-138.
31. Renton A.E., Majounie E., Waite A., Simón-Sánchez J., Rollinson S., Gibbs J.R., Schymick J.C., Laaksovirta H., van Swieten J.C., Myllykangas L., Kalimo H., Paetau A., Abramzon Y., Remes A.M., Kaganovich A., Scholz S.W., Duckworth J., Ding J., Harmer D.W., Hernandez D.G., Johnson J.O., Mok K., Ryten M., Trabzuni D., Guerreiro R.J., Orrell R.W., Neal J., Murray A., Pearson J., Jansen I.E., Sondervan D., Seelaar H., Blake D., Young K., Halliwell N., Callister J.B., Toulson G., Richardson A., Gerhard A., Snowden J., Mann D., Neary D., Nalls M.A., Peuralinna T., Jansson L., Isoviita V.M., Kaivorinne A.L., Hölttä-Vuori M., Ikonen E., Sulkava R., Benatar M., Wuu J., Chiò A., Restagno G., Borghero G., Sabatelli M., Heckerman D., Rogaeva E., Zinman L., Rothstein J.D., Sendtner M., Drepper C., Eichler E.E., Alkan C., Abdullaev Z., Pack S.D., Dutra A., Pak E., Hardy J., Singleton A., Williams N.M., Heutink P., Pickering-Brown S., Morris H.R., Tienari P.J., Traynor B.J. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 2011, 72:257-268. ITALSGEN Consortium.
32. Rosen D.R., Bowling A.C., Patterson D., Usdin T.B., Sapp P., Mezey E., McKenna-Yasek D., O'Regan J., Rahmani Z., Ferrante R.J., et al. A frequent ala 4 to val superoxide dismutase-1 mutation is associated with a rapidly progressive familial amyotrophic lateral sclerosis. Hum. Mol. Genet 1994, 3:981-987.
33. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J.P., Deng H.X., Rahmani Z., Krizus A., McKenna-Yasek D., Cayabyab A., Gaston S.M., Berger R., Tanzi R.E., Halperin J.J., Herzfeldt B., Van den Bergh R., Hung W., Bird T., Deng G., Mulder D.W., Smyth C., Laing N.G., Soriano E., Pericak-Vance M.A., Haines J., Rouleau G.A., Gusella J.S., Horvitz H.R., Brown R.H. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993, 4:59-62.
34. Schymick J.C., Scholz S.W., Fung H.C., Britton A., Arepalli S., Gibbs J.R., Lombardo F., Matarin M., Kasperaviciute D., Hernandez D.G., Crews C., Bruijn L., Rothstein J., Mora G., Restagno G., Chiò A., Singleton A., Hardy J., Traynor B.J. Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data. Lancet Neurol 2007, 6:322-328.
35. Seshadri S., Fitzpatrick A.L., Ikram M.A., DeStefano A.L., Gudnason V., Boada M., Bis J.C., Smith A.V., Carassquillo M.M., Lambert J.C., Harold D., Schrijvers E.M., Ramirez-Lorca R., Debette S., Longstreth W.T., Janssens A.C., Pankratz V.S., Dartigues J.F., Hollingworth P., Aspelund T., Hernandez I., Beiser A., Kuller L.H., Koudstaal P.J., Dickson D.W., Tzourio C., Abraham R., Antunez C., Du Y., Rotter J.I., Aulchenko Y.S., Harris T.B., Petersen R.C., Berr C., Owen M.J., Lopez-Arrieta J., Varadarajan B.N., Becker J.T., Rivadeneira F., Nalls M.A., Graff-Radford N.R., Campion D., Auerbach S., Rice K., Hofman A., Jonsson P.V., Schmidt H., Lathrop M., Mosley T.H., Au R., Psaty B.M., Uitterlinden A.G., Farrer L.A., Lumley T., Ruiz A., Williams J., Amouyel P., Younkin S.G., Wolf P.A., Launer L.J., Lopez O.L., van Duijn C.M., Breteler M.M. Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA 2010, 303:1832-1840. CHARGE ConsortiumGERAD1 ConsortiumEADI1 Consortium.
36. Shatunov A., Mok K., Newhouse S., Weale M.E., Smith B., Vance C., Johnson L., Veldink J.H., van Es M.A., van den Berg L.H., Robberecht W., Van Damme P., Hardiman O., Farmer A.E., Lewis C.M., Butler A.W., Abel O., Andersen P.M., Fogh I., Silani V., Chiò A., Traynor B.J., Melki J., Meininger V., Landers J.E., McGuffin P., Glass J.D., Pall H., Leigh P.N., Hardy J., Brown R.H., Powell J.F., Orrell R.W., Morrison K.E., Shaw P.J., Shaw C.E., Al-Chalabi A. Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study. Lancet Neurol 2010, 9:986-994.
37. Siddique T., Pericak-Vance M.A., Caliendo J., Hong S.T., Hung W.Y., Kaplan J., McKenna-Yasek D., Rimmler J.B., Sapp P., Saunders A.M., Scott W.K., Siddique N., Haines J.L., Brown R.H. Lack of association between apolipoprotein E genotype and sporadic amyotrophic lateral sclerosis. Neurogenetics 1998, 1:213-216.
38. Sreedharan J., Blair I.P., Tripathi V.B., Hu X., Vance C., Rogelj B., Ackerley S., Durnall J.C., Williams K.L., Buratti E., Baralle F., de Belleroche J., Mitchell J.D., Leigh P.N., Al-Chalabi A., Miller C.C., Nicholson G., Shaw C.E. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 2008, 319:1668-1672.
39. Traynor B.J., Codd M.B., Corr B., Forde C., Frost E., Hardiman O. Incidence and prevalence of ALS in Ireland, 1995-1997: a population-based study. Neurology 1999, 52:504-509.
40. Traynor B.J., Nalls M., Lai S.L., Gibbs R.J., Schymick J.C., Arepalli S., Hernandez D., van der Brug M.P., Johnson J.O., Dillman A., Cookson M., Moglia C., Calvo A., Restagno G., Mora G., Chiò A. Kinesin-associated protein 3 (KIFAP3) has no effect on survival in a population-based cohort of ALS patients. Proc. Natl. Acad. Sci. U. S. A. 2010, 6:12335-12338.
41. Valdmanis P.N., Dupre N., Bouchard J.P., Camu W., Salachas F., Meininger V., Strong M., Rouleau G.A. Three families with amyotrophic lateral sclerosis and frontotemporal dementia with evidence of linkage to chromosome 9p. Arch. Neurol 2007, 64:240-245.
42. van Es M.A., Van Vught P.W., Blauw H.M., Franke L., Saris C.G., Andersen P.M., Van Den Bosch L., de Jong S.W., van't Slot R., Birve A., Lemmens R., de Jong V., Baas F., Schelhaas H.J., Sleegers K., Van Broeckhoven C., Wokke J.H., Wijmenga C., Robberecht W., Veldink J.H., Ophoff R.A., van den Berg L.H. ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: a genome-wide association study. Lancet Neurol 2007, 6:869-877.
43. van Es M.A., van Vught P.W., Blauw H.M., Franke L., Saris C.G., Van den Bosch L., de Jong S.W., de Jong V., Baas F., van't Slot R., Lemmens R., Schelhaas H.J., Birve A., Sleegers K., Van Broeckhoven C., Schymick J.C., Traynor B.J., Wokke J.H., Wijmenga C., Robberecht W., Andersen P.M., Veldink J.H., Ophoff R.A., van den Berg L.H. Genetic variation in DPP6 is associated with susceptibility to amyotrophic lateral sclerosis. Nat. Genet 2008, 40:29-31.
44. van Es M.A., Veldink J.H., Saris C.G., Blauw H.M., van Vught P.W., Birve A., Lemmens R., Schelhaas H.J., Groen E.J., Huisman M.H., van der Kooi A.J., de Visser M., Dahlberg C., Estrada K., Rivadeneira F., Hofman A., Zwarts M.J., van Doormaal P.T., Rujescu D., Strengman E., Giegling I., Muglia P., Tomik B., Slowik A., Uitterlinden A.G., Hendrich C., Waibel S., Meyer T., Ludolph A.C., Glass J.D., Purcell S., Cichon S., Nöthen M.M., Wichmann H.E., Schreiber S., Vermeulen S.H., Kiemeney L.A., Wokke J.H., Cronin S., McLaughlin R.L., Hardiman O., Fumoto K., Pasterkamp R.J., Meininger V., Melki J., Leigh P.N., Shaw C.E., Landers J.E., Al-Chalabi A., Brown R.H., Robberecht W., Andersen P.M., Ophoff R.A., van den Berg L.H. Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis. Nat. Genet 2009, 41:1083-1087.
45. Vance C., Rogelj B., Hortobágyi T., De Vos K.J., Nishimura A.L., Sreedharan J., Hu X., Smith B., Ruddy D., Wright P., Ganesalingam J., Williams K.L., Tripathi V., Al-Saraj S., Al-Chalabi A., Leigh P.N., Blair I.P., Nicholson G., de Belleroche J., Gallo J.M., Miller C.C., Shaw C.E. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 2009, 323:1208-1211.
46. Weisskopf M.G., Gallo V., O'Reilly E.J., Vineis P., Ascherio A. Smoking may be considered an established risk factor for sporadic ALS. Neurology 2010, 74:1927-1928.
47. Worms P.M. The epidemiology of motor neuron diseases: a review of recent studies. J. Neurol. Sci 2001, 191:3-9.
48. Wroe R., Wai-Ling Butler A., Andersen P.M., Powell J.F., Al-Chalabi A. ALSOD: the Amyotrophic Lateral Sclerosis Online Database. Amyotroph Lateral Scler 2008, 9:249-250.
49. Zoccolella S., Beghi E., Palagano G., Fraddosio A., Samarelli V., Lamberti P., Lepore V., Serlenga L., Logroscino G. Signs and symptoms at diagnosis of amyotrophic lateral sclerosis: a population-based study in southern Italy. Eur. J. Neurol 2006, 13:789-792. SLAP Registry.